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A population-specific reference
panel empowers genetic studies of
Anabaptist populations
Liping Hou1, Rachel L. Kember2, Jared C. Roach3, Jeffrey R. O’Connell4, David W. Craig5,
Maja Bucan2, William K. Scott 6, Margaret Pericak-Vance6, Jonathan L. Haines 7,
Michael H. Crawford8, Alan R. Shuldiner4 & Francis J. McMahon 1
Genotype imputation is a powerful strategy for achieving the large sample sizes required for
identification of variants underlying complex phenotypes, but imputation of rare variants remains
problematic. Genetically isolated populations offer one solution, however population-specific reference
panels are needed to assure optimal imputation accuracy and allele frequency estimation. Here we
report the Anabaptist Genome Reference Panel (AGRP), the first whole-genome catalogue of variants
and phased haplotypes in people of Amish and Mennonite ancestry. Based on high-depth wholegenome sequence (WGS) from 265 individuals, the AGRP contains >12 M high-confidence single
nucleotide variants and short indels, of which ~12.5% are novel. These Anabaptist-specific variants
were more deleterious than variants with comparable frequencies observed in the 1000 Genomes
panel. About 43,000 variants showed enriched allele frequencies in AGRP, consistent with drift.
When combined with the 1000 Genomes Project reference panel, the AGRP substantially improved
imputation, especially for rarer variants. The AGRP is freely available to researchers through an
imputation server.
Genetically isolated populations are subgroups that have remained reproductively separated from the surrounding population over many generations. Genetic isolates are often descended from a limited number of founding
individuals and may suffer an increased burden of inherited disease. However, genetic isolates also offer many
advantages for genetic studies1, so have long been of interest to geneticists1–3. Compared with outbred populations, population isolates generally have reduced genetic diversity due to founder effects1, 4. Individuals from
isolated populations may also share more uniform environments, decreasing the non-genetic sources of variance
contributing to complex traits. Some population isolates also have well-maintained genealogical records, which
can facilitate family ascertainment and estimation of population parameters. Previous studies in population isolates have successfully identified genes and variants associated with Mendelian5 and complex traits4, 6.
Anabaptists represent a genetic isolate comprising several groups, including Amish and Mennonites, whose
European ancestors settled in the Americas starting in the 17th century7. Owing to religious conviction, cultural differences, and rural living, most Anabaptists have remained genetically distinct, despite rapid population expansion in recent decades8, 9. A number of otherwise rare Mendelian disorders have been identified
among Anabaptists, with distinctive spectra of observed mutations characteristic of strong founder effects10, 11.
High-throughput sequencing has renewed interest in the study of Anabaptist groups as a means of identifying
genes underlying common, complex traits9, 12.
Since whole genome sequencing (WGS) is still expensive in large samples, many study designs rely on genotype imputation of unsequenced individuals. Several existing methods can use a framework of common variants
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SNV
Genome

Synonymous

Nonsynonymous

Indels

LoF

Total variants
Number of variants

12.3 million

40,416

47,270

993,567

2,458

Novelty ratea

12.5%

3.95%

7.96%

21.9%

35.5%

Total variation by frequencyb
50.2%

45.8%

34.1%

41.9%

17.7%

Low frequency (MAF 0.5–5%) 31.2%

Common (MAF > 5%)

33.8%

37.8%

30.9%

31.5%

Rare (MAF < 0.5%)

20.4%

28.1%

27.3%

50.9%

18.5%

Variants per individual
5th percentile

3,178,457

9,242

8,097

189,720

166

Average

3,247,725

9,815

8,518

197,563

183

95th percentile

3,325,349

10,059

8,734

203,980

200

Table 1. Discovered autosomal variants. aVersus Kaviar, dbSNP 144, and ExAC. bAllele frequencies estimated
in AGRP.

(obtained, e.g., from a SNP array) to infer genotypes from local haplotypes represented within a reference panel
of sequenced individuals13. Common alleles can be imputed with high accuracy, but imputation of rarer alleles
can be challenging13. In isolated populations, imputation of rarer alleles can be improved by population specific
reference panels that better represent founder alleles and haplotypes6, 14.
Here we present Phase 1 of the Anabaptist Genome Reference Panel (AGRP), the first whole-genome,
population-specific imputation reference panel drawn from people of Anabaptist ancestry. The AGRP is built
upon high-depth WGS data obtained from 265 individuals of Amish or Mennonite ancestry. We describe the
population structure and allele frequency spectra represented by the AGRP and estimate the impact of this reference panel on the imputation accuracy of variants across the full range of allele frequencies.

Results

Sequencing and variant yield. Within each sequenced individual, we identified an average of 3.2 million

autosomal variants, including 8,518 non-synonymous SNVs, 179 indels, and 183 putative loss of function (LoF)
variants. In total, we identified ~12.3 million variants across all 265 Anabaptist individuals, including 993,567
indels and 2,458 putative LoF variants (Table 1). About 12.5% of the identified variants were novel (including
~11.1% of SNVs and ~21.9% of indels), defined here as variants not present in Kaviar15, dbSNP (v144) or ExAC
(v0.3)16. Of all identified variants, 92,440 (0.75%) overlapped with protein-coding sequences; 47,270 (51.1%)
of these were non-synonymous variants. Overall, ~18.5% of the identified variants were rare (MAF < 0.5%).
However, a higher proportion of the non-synonymous variants (~28.1%), and an even higher proportion of the
LoF variants (~50.9%) were also rare. This is consistent with negative selection.
Genotype calls were highly consistent between duplicate samples and across genotype platforms. Genotype
concordance rates calculated based on two pairs of duplicate samples were 99.9% for SNVs and 97.0% for indels
and substitutions. SNV concordance rate was 99.7% within a subset of 46 individuals whose DNA was also genotyped with the Illumina OmniExpress Exome SNP array (no indels or substitutions are represented on this array).
Using the same SNP array data, we also estimated the sensitivity of the WGS platform to detect SNVs. Of the
640,931 high quality SNV sites identified by the array, 631,579 (98.5%) sites were also identified within our WGS
data. The SNV detection sensitivity was similar across a range of MAF values (Figure S1).
Many Anabaptist populations suffer from high rates of otherwise rare Mendelian diseases7. Thus we investigated whether variants seen only in the AGRP were more deleterious, as estimated by the Combined Annotation
Dependent Depletion (CADD) score17, than variants of comparable frequencies that were also identified in the
1000 Genomes Project sample. Indeed, both coding and non-coding variants seen only in the AGRP were significantly more deleterious (p < 0.0001; Fig. 1). The AGRP contains some individuals with psychiatric or metabolic
disorders, so we repeated this analysis in only the healthy individuals. The results were similar (data not shown).

Imputation.

One of the main goals of this project was to provide a population-specific reference panel for
genotype imputation in individuals of Anabaptist ancestry. Here we evaluated the accuracy with which variants
of various MAF could be imputed. In order to illustrate the specific contribution of the AGRP to imputation
accuracy, we reserved 10 individuals from the AGRP as a test subset and evaluated the results in four different
reference panel configurations: (1) the AGRP alone; (2) the 1000G panel alone; (3) a merged panel comprising
both 1 and 2; and (4) the Haplotype Reference Consortium (HRC) reference panel.
The merged AGRP and 1000G reference panel provided the highest imputation accuracy across all allele
frequency bins (Fig. 2A). The greatest advantage was observed for rarer alleles. For example, alleles with a 1000G
MAF < 0.5% were imputed at an aggregate r2 of 0.74 with the merged AGRP/1000G panel, compared to 0.68 with
the HRC panel, 0.55 with the AGRP alone, and 0.46 with the 1000G panel alone.
The AGRP also enabled imputation of a large number of variants apparently unique to Anabaptists. Overall,
~14.4% of variants identified in the AGRP were not present in the 1000G and ~18.3% were not present in the
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Figure 1. Variants seen only in AGRP are more deleterious. Mean Combined Annotation Dependent Depletion
(CADD) scores for AGRP-specific variants (red) and those shared with the 1000G sample (blue), annotated as
non-coding (solid lines) or coding (dotted lines), and binned by minor allele frequency.

Figure 2. Imputation of shared and AGRP-specific variants. (A) Imputation accuracy (aggregate squared
Pearson correlation coefficient, r2), across various reference panel configurations. The x-axis (log scale) shows
the 1000G EUR (non-refernce) allele frequency of the variants being imputed. (B) The stacked bars show
proportions of variants found in AGRP (left y-axis) that were also shared by various reference panels across
a range of (non-reference) allele frequency bins in the AGRP. The embedded black line shows the imputation
accuracy of AGRP-specific variants (right y-axis) when the merged AGRP/1000G reference panel was used.

HRC panel. Although some (52.8%) of these Anabaptist-specific variants were very rare and thus un-imputable,
the remaining variants could be imputed well, with aggregate r2 values in the 0.60–0.98 range (Fig. 2B).

Genetic differentiation. Principal components analysis (PCA) showed that individuals in the AGRP
clustered with CEU participants from the HapMap project (Fig. 3), as expected. In agreement with the PCA
results, the overall correlation of MAF values in the AGRP and the European-ancestry subset of 1000G was high
(r2 = 0.97, Figure S2). For uncommon variants, however, the correlation was much lower. Variants with 1000G
MAF < 5% were only weakly correlated with MAF estimated in AGRP (r2 = 0.24). Consistent with this result,
42,837 variants were rare or absent in 1000G (MAF < 0.5%) but reached frequencies >5% in AGRP (Table S1).
It is widely believed that founder effects (i.e., population bottlenecks and genetic drift) influence the structure
of Anabaptist populations8, 18, but the magnitude of these influences is largely unknown. Since founder effects lead
to depletion of variants that are rare in the ancestral population19, we sought to estimate the footprint of founder
effects in today’s Anabaptists by assessing depletion of rare variants in AGRP. The numbers of variants detected
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Figure 3. Plots of the first two principal components derived from the AGRP samples. (A) AGRP samples
(black dots) are plotted along with European (CEU, red dots), Asian (CHB + JPT, violet dots), and African (YRI,
green dots) samples taken from HapMap phase 3. (B) Mennonite (grey dots), Midwestern Amish (blue dots),
and Lancaster County Amish (orange dots) within the AGRP, and CEU (red dots) from HapMap phase 3.

Figure 4. Variant counts by MAF group. The error bars for EUR (Europeans) were estimated based on 10 subsamples of 102 randomly-selected Europeans in the 1000G sample.

in unrelated individuals in AGRP (defined as less than third-degree relatives by KING20) were compared to those
detected in European-ancestry subsets of the 1000G panel that were matched to AGRP on sample size.
A total of ~12.07 M rare variants (MAF ≤ 0.5%) are reported among the 500 unrelated European-ancestry
samples in the 1000G panel. The subsets of 102 unrelated Europeans sampled from 1000G carried a mean of
3,545 K ± 77 K of these rare variants. Among the 102 unrelated Anabaptists in AGRP, however, only 995 K rare
variants were identified (Fig. 4). This suggests a substantial depletion of rare variants in Anabaptists compared to
outbred Europeans. The AGRP also contained significantly fewer variants with MAF between 0.5% and 5%, but
the depletion compared to 1000G was modest. The number of common variants (MAF > 5%) was similar in both
groups (Fig. 4).
The improved imputation accuracy conferred by the AGRP could be attributed, at least in part, to increased
distant relatedness and reduced genetic diversity, both thought to characterize people of Anabaptist ancestry8, 21.
To investigate distant relatedness, we compared the proportion of the genome shared identical by descent (IBD)
among individuals within the AGRP to that shared between AGRP and ancestral Europeans in the 1000G. IBD
sharing was substantially greater within the AGRP than within 1000G (Fig. 5): 44% of AGRP pairs shared at
least 1% of the genome IBD, while >95% of 1000G pairs shared almost none of the genome IBD (<0.25%).
Furthermore, very little IBD sharing (<0.5%) was detected between individuals in AGRP and individuals
in1000G, demonstrating that the AGRP provides a sample of the ancestral European genome that is largely distinct from that represented by the1000G.
To investigate one measure of genetic diversity, we compared the total length of the genome shared homozygous by descent (HBD) among individuals within the AGRP to that shared between AGRP and Europeans in
the 1000G. Total HBD length was significantly greater in AGRP than in 1000G (P < 0.001; Fig. 6). Total HBD
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Figure 5. Increased distant relatedness among Anabaptists. The distribution, over all pairs of individuals, of
the fraction of the genome shared IBD (segment lengths ≥3 cM) either within AGRP (Anabaptist, blue), within
Europeans (EUR, grey), or between Anabaptists and EUR (orange).

Figure 6. Reduced Genetic Diversity within Anabaptists. Total length of the genome homozygous by descent
(HBD) within Europeans from the 1000G Project (EUR) and within various Anabaptist groups represented in
the Phase I AGRP.

length varied among the Anabaptist groups represented in the AGRP. The longest HBD regions were observed
among Amish living in Lancaster County, Pennsylvania, followed by Amish living in the Midwestern United
States. Mennonites in AGRP carried HBD regions that were only slightly longer on average than those observed
in 1000G.

Discussion

Imputation of SNP-array genotypes against a suitable reference panel represents an efficient and cost-effective
strategy for investigating genetic variants not directly represented on inexpensive SNP arrays. However, current reference panels do not always perform well for rare variants and do not capture all of the rare variation
present in human populations22. Our findings demonstrate the value of a population-specific reference panel
for studies of Anabaptist founder populations. The AGRP effectively boosted imputation accuracy, especially
for variants that are relatively rare. The increased imputability of rare variants seems to be explained by several
key factors: 1) increased frequency of some otherwise rare alleles, presumably due to drift; 2) distant relatedness
and decreased genetic diversity among Anabaptists, so that each rare allele is more likely to be represented on a
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single founder haplotype; 3) increased phasing accuracy due to family-relationship aware phasing methods and
increased homozygosity by descent, which also increases the length of imputable haplotypes.
The AGRP performed best when merged with an existing large reference panel from the 1000G Project.
Similar results have been observed in studies of other population-specific reference panels23. Increasing sample
size will likely continue to improve imputation performance, consistent with what has been found by the 1000G
Project24 and The Haplotype Reference Consortium25. Most important for studies of Anabaptist populations,
the AGRP enables imputation of a large number of variants apparently unique to Anabaptists. We have shown
that such variants tend to be more deleterious than variants of similar MAF that are also seen outside Anabaptist
populations.
Footprints of the unique histories of Anabaptist populations are evident within the whole genome sequences
represented by the AGRP. Common variants showed comparable allele frequencies in the AGRP and 1000G
European panel, consistent with previous findings26. For rare variants, however, the allele frequencies were often
quite different. Many variants rare or absent in the 1000G panel reached appreciable frequencies in the AGRP.
On the other hand, many rare variants found in the 1000G panel were not detected in the AGRP, suggesting that
these variants did not survive the population bottlenecks that occurred early in the Anabaptist population history
or were lost due to random drift.
The substantial reduction of rare variants we observed in the AGRP is consistent with previous studies of
other founder populations19, 27, but has not, to our knowledge, been previously demonstrated within Anabaptists.
Since we did not sequence a comparable group of outbred Europeans in the present study, some of the differences
we observed in the abundance of rare variants may be attributable to the sequencing platform and data analysis
pipeline we used. However, it is unlikely that methodological differences alone can account for the substantial
depletion of rare variants observed within the AGRP, since we detected no substantial difference in the sensitivity
of variant calls across a broad range of minor allele frequencies (Figure S1).
Principal Components Analysis (PCA) analysis showed that the Anabaptist sample we studied was closely
clustered with the Northern and Western European ancestry samples from HapMap. This is not surprising in light
of the known recent European ancestry of Anabaptist groups. However, a finer scale PCA analysis was able to distinguish several different sub-populations within the AGRP, which corresponded roughly to known geographic
and religious distinctions that have influenced Anabaptist mating patterns for most of the last 3 centuries7. Similar
differences were also seen in the HBD analysis. These results suggest that the AGRP may perform better when
used with studies of the Amish, but should still have value in other Anabaptist populations. The AGRP thus complements ongoing projects, such as TOPMed (G.R. Abecasis et al., 2015 ASHG, abstract) that include individuals
drawn from the Amish communities in Lancaster, PA and surrounding areas.
This study has several limitations. First, the sample size is relatively small. This reduces representation of rare
alleles and haplotypes. However, this only leads to underestimation of the value of the AGRP for imputation of
rare alleles. The sample size also limits precision of allele frequency estimates, especially for alleles that are rare
in Anabaptists. While important, this does not vitiate the AGRP for filtering variants that have drifted to high
frequencies in Anabaptist populations and are thus unlikely to be highly deleterious. Second, allele frequencies should ideally be estimated separately for each subpopulation identified by the PCA analysis, but this will
require a much larger sample size, especially for rare variants. Third, this Phase I of the AGRP mainly represents
individuals of Amish ancestry. Mennonites, Brethren, Hutterites, and other Anabaptist groups are not well represented. Phase II of the AGRP is underway and will include a better representation of Mennonites, including
those of Dutch-German ancestry (so-called “Russian Mennonites”.) Fourth, the AGRP is not a randomly selected
sample of Anabaptists, but was based on sequences collected in the course of various common disease studies.
While an epidemiological sample ascertained without regard to phenotype has advantages, inclusion of cases
may actually increase the value of the AGRP for future studies focused on the same (or related) diseases, since
any disease-associated alleles will presumably be better represented. Intuitively, inclusion of people with diseases
caused by alleles of large effect could affect imputation of nearby alleles, but this is unlikely to be an important
factor for the common, complex diseases represented within the AGRP. Indeed, a previous study concluded “No
loss of imputation quality was observed using a panel built from phenotypic extremes”28.
We hope that the AGRP will facilitate a broad range of genomic studies in Anabaptist communities. The
AGRP is available through an imputation server at https://www.nimh.nih.gov/labs-at-nimh/research-areas/
clinics-and-labs/hgb/data-downloads.shtml.

Methods

Sample selection. WGS data were submitted by each of the collaborating groups, including: 106 individuals

of Amish or Mennonite ancestry collected by the Human Genetics Branch, NIMH IRP and submitted by FJM,
LH, and ISB (58 of whom suffered from a mood disorder), 81 individuals of Amish or Mennonite ancestry collected through the University of Maryland’s Amish Research Clinic in Lancaster, PA and submitted by ARS & JRO
(38 of whom suffered from hypertension or a metabolic disorder); and 80 individuals of Amish ancestry collected
by Janice Egeland and colleagues12 and submitted by MB & RLK (35 of whom suffered from bipolar disorder). All
participants provided informed consent that explicitly allowed their coded genome sequencing data to be shared
with other investigators. The final data set comprised WGS data from 267 individuals, including two pairs of
duplicate samples that were used to evaluate sequencing and genotype accuracy.

Sequencing and data generation. DNA derived from whole blood or from lymphoblastoid cell lines
was obtained from the Rutgers University Cell and DNA Repository (Rutgers, NJ), the Corriell Institute
(Camden, NJ), or the University of Maryland Amish Research Program. WGS was performed to >30× coverage
by Complete Genomics, Inc. (CGI) using CGI’s combinatorial probe–anchor ligation (cPAL) method29. SNVs,
SCIENtIfIC REPOrtS | 7: 6079 | DOI:10.1038/s41598-017-05445-3
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insertions, and deletions were called with the CGI analysis pipeline version 2.0, 2.4 or 2.5 (described in refs 29, 30),
relative to the human reference genome, GRCh37.
The CGA tools mkvcf command was used by each group to generate VCF files, which include all sites where at
least one subject carried a non-reference allele. To confirm that the VCF files included the same types of variants
and the genotype data had the same format, the same parameters (–source-names masterVar–field-names GT,
FT, GQ, GL, DP, AD) were used by each group. The “–source-names masterVar” parameter asks the CGA tools to
extract variants only from the masterVar files, so that only SNVs and short indels are included in the VCF files,
while CNVs, SVs, and mobile element insertions (MEIs) are excluded. The “–field-names GT, FT, GQ, GL, DP,
AD” parameter asks CGA tools to extract more information for each genotype call. Particularly, for non-reference
genotype calls, CGA tools extracts GT (Genotype), FT (Genotype filters), GQ (Genotype Quality), GL (Genotype
Likelihood), DP (Total Read Depth), and AD (Allelic depths) from the raw data. Previous studies have shown that
false positive rates are higher for CNVs, SVs and MEIs than for SNVs in CGI data14, so these classes of variation
were excluded from the reference panel.

Quality control and variant annotation. All multi-allelic variants and variants located on non-autosomal

chromosomes were removed from all three VCF files. All low-quality (marked by mkvcf as low quality; genotype
quality <20; allele balance ratio <0.25 or >0.75 (applies to heterozygotes only); read depth <8) and half-called
genotypes were set to ‘missing’. To make sure all variants were consistently represented in each VCF file, we
normalized all VCF files using the VT variant tool set31. We then merged all VCF files and back-filled missing
genotypes based on individual masterVar files. All Mendelian-inconsistent genotypes were set to missing. After
QC, some variant sites no longer showed non-reference alleles; these were excluded. As the final QC step, variants with a missing rate >25%, Mendelian error rate >10% (based on 80 trios), or Hardy-Weinberg Equilibrium
P < 1.0 × 10−6 were also excluded.
We assessed the accuracy of the sequencing data by: 1) comparing the genotype concordance rate within
two pairs of duplicate samples; and 2) comparing the genotype concordance rate across 46 sequenced samples
that were also genotyped with the Illumina OmniExpress Exome SNP array. We also used the same SNP array
data to estimate the power of the sequencing pipeline to detect SNVs. Particularly, we calculated the fraction of
high-quality variant calls (minor allele count >0, missing rate <5%, HWE p > 0.0001) detected by SNP array that
were also identified in the CGI data.
All variants called in the AGRP were annotated with Combined Annotation Dependent Depletion (CADD)
raw scores17, Ensembl Gene annotation, and 1000G (Aug 2015) allele frequencies, using ANNOVAR32. Variants
were split into either ‘coding’ or ‘non-coding’ according to the Ensembl gene model, and categorized as “shared”
if they were also identified in the 1000G. Otherwise variants were categorized as “AGRP-specific.” The Wilcoxon
rank-sum test was used to test variants for association between sharing status and raw CADD scores. Since
CADD scores are highly correlated with functional annotation and allele frequency17, separate comparisons were
carried out for coding and non-coding variants within each of 3 AGRP allele frequency bins.

Reference panel construction.

To build the AGRP, we first phased the genomes with SHAPEIT233. All
known relationships were provided for phasing and the–duohmm option was enabled to make SHAPEIT2 incorporate pedigree information into the haplotype estimates, which has been shown to greatly improve the phasing
accuracy34. In order to keep as many as haplotypes as possible but remove duplicate haplotypes for the final
reference panel, we used KING20 to extract 131 individuals who were unrelated at the first-degree level. Thus 262
phased genomes were extracted to build the reference panel.

Imputation.

To assess imputation accuracy, we randomly selected a “test set” of 10 individuals from the
AGRP. In the test set, autosomal genotypes were masked at all variable sites not represented on the Illumina
Human OmniExpress SNP array. We chose this array since it represents an inexpensive and widely used array
with over 700K SNPs common among people of European ancestry (http://www.illumina.com/products/human_
omni_express_beadchip_kits.html).
Masked sites were then imputed by IMPUTE2 against: 1) the remaining AGRP, 2) the latest (phase 3) 1000
Genomes Project (1000G) reference panel alone, and 3) a merged panel comprising both the AGRP and the
1000G reference panel.
We also uploaded the phased VCF file of the test set to the Sanger Imputation Service (https://imputation.sanger.ac.uk/) and imputed the masked sites with the PBWT35 pipeline against the Haplotype Reference
Consortium (r1.1) reference panel36. Variant sites were divided into 14 bins, based on MAF in the 1000G panel.
Imputation accuracy was measured within each MAF bin as the aggregate squared Pearson correlation coefficient
(r2) between imputed and actual allele dosages at the masked sites. To ensure comparability across the various
reference panel configurations, only variants present in all panels were included in this comparison.

Allele frequencies estimation and Population structure. The best linear unbiased estimator (BLUE)37,

designed to estimate allele frequencies for complex pedigrees, was used to estimate the allele frequencies for all
variants identified in the 265 Anabaptists. To infer population structure, principal-component analysis (PCA)
was performed using ~100K LD-pruned SNPs. Since the sample included related individuals, we used a method
called Principal Components Analysis in Related Samples (PC-AiR)38, which identifies principal components that
accurately capture population structure, rather than family structure. We ran PC-AiR twice: once with HapMap
Phase 3 data (from YRI, CEU, and CHB + JPT) and once with the CEU subset only. We did this to illustrate how
AGRP individuals compare to the HapMap reference groups and to explore population structure within AGRP.
Founder effects may lead to depletion of rare variants19. To explore this phenomenon in the AGRP, we first
extracted a list of unrelated individuals from the full set of 265 Anabaptists using KING20. We kept only one
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individual from each cluster of those with inferred relationships up to the 3rd degree, leaving 102 unrelated
Anabaptists for this analysis. Using the same method, we also extracted all unrelated individuals from the
European genomes in the final release of the 1000G Project, then randomly selected 102 of these for comparison. We compared the counts of variants in these 1000G individuals with counts in the 102 Anabaptists, across
various allele-frequency bins. We performed this comparison 10 times by randomly selecting (with replacement)
102 individuals from the 500 unrelated Europeans in 1000G. By this procedure, we hoped to distinguish a true
depletion of rare variants – which should be confined to variants with lower allele frequencies – from differences
attributable to sequencing platform or variant calling pipeline, which should affect a broad range of allele frequencies, or differences due simply to sample size. We used only SNVs in this analysis, since other variant classes are
called less accurately and are more sensitive to differences in sequencing platforms and pipelines.

Identity-by-Descent (IBD) and Homozygosity-by-Descent (HBD).

Population isolates such as the
Anabaptists often show increased IBD and HBD, owing to founder effects, inbreeding, and other population
forces2. Such increases may increase imputation accuracy by improved phasing39. To assess these phenomena in
the AGRP, we identified IBD and HBD regions with IBDseq40, a method designed specifically to identify such
regions in WGS data. To compare the IBD sharing among Anabaptists, among other Europeans, and between
Anabaptists and other Europeans, we merged WGS data from the AGRP with WGS data from the 503 other
Europeans in the 1000G Project and used only the overlapping variants. We also compared the total length of
HBD regions in both groups.

References

1. Peltonen, L., Palotie, A. & Lange, K. Use of population isolates for mapping complex traits. Nature reviews Genetics 1, 182–190
(2000).
2. Arcos-Burgos, M. & Muenke, M. Genetics of population isolates. Clinical genetics 61, 233–247 (2002).
3. Hatzikotoulas, K., Gilly, A. & Zeggini, E. Using population isolates in genetic association studies. Briefings in functional genomics 13,
371–377 (2014).
4. Kristiansson, K., Naukkarinen, J. & Peltonen, L. Isolated populations and complex disease gene identification. Genome biology 9, 109
(2008).
5. Peltonen, L., Jalanko, A. & Varilo, T. Molecular genetics of the Finnish disease heritage. Human molecular genetics 8, 1913–1923
(1999).
6. Sidore, C. et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood
inflammatory markers. Nature genetics 47, 1272–1281 (2015).
7. Nolt,, S. M. A History of the Amish: Third Edition Good Books (2016).
8. Strauss, K. A. & Puffenberger, E. G. Genetics, medicine, and the Plain people. Annual review of genomics and human genetics 10,
513–536 (2009).
9. Hou, L. et al. Amish revisited: next-generation sequencing studies of psychiatric disorders among the Plain people. Trends in
genetics: TIG 29, 412–418 (2013).
10. McKusick, V. A., Egeland, J. A., Eldridge, R. & Krusen, D. E. Dwarfism in the Amish I. The Ellis-Van Creveld Syndrome. Bulletin of
the Johns Hopkins Hospital 115, 306–336 (1964).
11. Puffenberger, E. G. Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania. American journal of medical
genetics Part C, Seminars in medical genetics 121C, 18–31 (2003).
12. Georgi, B. et al. Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate. PLoS genetics 10,
e1004229 (2014).
13. Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nature reviews Genetics 11, 499–511 (2010).
14. Carmi, S. et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish
and European origins. Nature communications 5, 4835 (2014).
15. Glusman, G., Caballero, J., Mauldin, D. E., Hood, L. & Roach, J. C. Kaviar: an accessible system for testing SNV novelty.
Bioinformatics 27, 3216–3217 (2011).
16. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
17. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nature genetics 46,
310–315 (2014).
18. Crawford, M. H., Dykes, D. D. & Polesky, H. F. Genetic structure of Mennonite populations of Kansas and Nebraska. Human biology
61, 493–514 (1989).
19. Chheda, H. et al. Whole genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland
and United Kingdom. bioRxiv (2016).
20. Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873 (2010).
21. Khoury, M. J., Cohen, B. H., Diamond, E. L., Chase, G. A. & McKusick, V. A. Inbreeding and prereproductive mortality in the Old
Order Amish. I. Genealogic epidemiology of inbreeding. American journal of epidemiology 125, 453–461 (1987).
22. Pistis, G. et al. Rare variant genotype imputation with thousands of study-specific whole-genome sequences: implications for costeffective study designs. European journal of human genetics: EJHG 23, 975–983 (2015).
23. Genome of the Netherlands C. Whole-genome sequence variation, population structure and demographic history of the Dutch
population. Nature genetics 46, 818–825 (2014).
24. Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
25. McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. bioRxiv (2016).
26. Van Hout, C. V. et al. Extent and distribution of linkage disequilibrium in the Old Order Amish. Genetic epidemiology 34, 146–150
(2010).
27. Lim, E. T. et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS genetics 10,
e1004494 (2014).
28. Duan, Q. et al. Imputation of coding variants in African Americans: better performance using data from the exome sequencing
project. Bioinformatics 29, 2744–2749 (2013).
29. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78–81
(2010).
30. Carnevali, P. et al. Computational techniques for human genome resequencing using mated gapped reads. Journal of computational
biology: a journal of computational molecular cell biology 19, 279–292 (2012).
31. Tan, A., Abecasis, G. R. & Kang, H. M. Unified representation of genetic variants. Bioinformatics 31, 2202–2204 (2015).
32. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Nucleic acids research 38, e164 (2010).

SCIENtIfIC REPOrtS | 7: 6079 | DOI:10.1038/s41598-017-05445-3

8

www.nature.com/scientificreports/
33. Delaneau, O., Zagury, J. F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nature
methods 10, 5–6 (2013).
34. O’Connell, J. et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS genetics 10, e1004234
(2014).
35. Durbin, R. Efficient haplotype matching and storage using the positional Burrows-Wheeler transform (PBWT). Bioinformatics 30,
1266–1272 (2014).
36. McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nature genetics 48, 1279–1283 (2016).
37. McPeek, M. S., Wu, X. & Ober, C. Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics 60, 359–367
(2004).
38. Conomos, M. P., Miller, M. B. & Thornton, T. A. Robust inference of population structure for ancestry prediction and correction of
stratification in the presence of relatedness. Genetic epidemiology 39, 276–293 (2015).
39. Kong, A. et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nature genetics 40, 1068–1075 (2008).
40. Browning, B. L. & Browning, S. R. Detecting identity by descent and estimating genotype error rates in sequence data. American
journal of human genetics 93, 840–851 (2013).

Acknowledgements

This research was funded by the National Institute of Mental Health (NIMH) Intramural Research Program
(ZIA-MH00284311; NCT00001174). NIH: Miami and CWRU samples in phase II were collected with
support from R01AG019085 (JLH), R01AG019726 (WKS) and R01EY023164 (MPV). This work utilized the
computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).

Author Contributions

F.J.M. supervised and coordinated the Anabaptist Genome Reference Panel project. R.L.K., J.C.R., J.R.O., M.B.,
W.K.S., M.P.-V., J.L.H., M.H.C., A.R.S., and F.J.M. provided whole genome sequence data. L.H. and R.L.K.
performed in-depth data analyses. L.H. and F.J.M. wrote and revised the manuscript. R.L.K., J.C.R., J.R.O.,
D.W.C., M.B., W.K.S., M.P.-V., J.L.H., M.H.C., A.R.S. provided critical amendments and edited the manuscript.

Additional Information

Supplementary information accompanies this paper at doi:10.1038/s41598-017-05445-3
Competing Interests: Alan R. Shuldiner is an employee of Regeneron Genetics Center, Regeneron
Pharmaceuticals, Inc. The other authors declare no competing financial interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2017

SCIENtIfIC REPOrtS | 7: 6079 | DOI:10.1038/s41598-017-05445-3

9

